Systems of Care: Need for Hub-and-Spoke Systems for Both Primary and Systematic Percutaneous Coronary Intervention After Fibrinolysis
Year: 2008
Type: editorial
Abstract: P rimary percutaneous coronary intervention (PCI) iscurrently considered the best reperfusion therapy if performed in a timely manner.However, in many developed countries, it is difficult to offer primary angioplasty to more than 20% to 30% of eligible patients because of logistical issues.Fibrinolytic therapy has recently improved, with the addition of clopidogrel resulting in both improved infarct artery patency 1 and mortality 2 and enoxaparin reducing reinfarction.3 In addition, rescue PCI has been shown to reduce reinfarction after fibrinolytic therapy by 42% (PϽ0.05), 4 and in a meta-analysis of 8 trials that included 1117 patients, rescue PCI resulted in a reduction in death, reinfarction, and heart failure at 6 months from 41.0% to 29.2% (PϽ0.001) compared with fibrinolysis and PCI only for recurrent ischemia.5 There also was a trend for a reduction in mortality (odds ratio [OR], 0.69; 95% CI, 0.46 to 1.05; Pϭ0.09). Article p 268For many years, it has been controversial as to whether coupling PCI with fibrinolysis to ensure durable patency of the infarct-related artery is beneficial or harmful.Earlier trials, often without aspirin and without stenting, showed harm, 6 and recent facilitated angioplasty trials (fibrinolysis followed by rapid PCI) also have shown harm or no benefit.[7][8][9] This is probably due to the prothrombotic milieu induced by fibrinolytic therapy in the first few hours after administration.At a later time point, when the prothrombotic situation has lessened and glycoprotein IIb/IIIa antagonists have been administered, systematic PCI may be beneficial.A number of recent trials help clarify the optimal timing of systematic PCI after fibrinolysis (the Figure).Less than 3 hours is harmful, and there seems to be a window between 3The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.
Source: Circulation
Author: Harvey D. White
Institution: Auckland City Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Medicines Company
OpenAlex ID: W2131772857
